dihexa retracted paper controversy Two papers for plagiarizing a 50-year-old thesis – Retraction Watch Controversial 'cost of autism' paper

Your dedicated wellness advisor and provider will work closely with you to ensure peptide therapy administration is going to be effective and meet your goals

The COVID-19 vaccine is no exception

Most published information currently comes from: While many findings appear promising, additional research is needed to better understand long-term safety, effectiveness, dosing protocols, and potential risks in diverse patient populations

Published September 9, 2021

Health alert Status: Active Date issued: 19 June 2026 Issued by: Dr Caroline McElnay, Chief Health Officer Issued to: Health professionals and the Victorian community Key messages The department has been notified of six cases of acute liver toxicity associated with an unapproved peptide product in Australia, labelled Retatrutide

Animal studies have shown that co-administration of BPC-157 NSAID therapies can almost completely prevent the formation of gastric lesions